Literature DB >> 9033653

Establishment and characterization of human gastric carcinoma cell lines.

J G Park1, H K Yang, W H Kim, J K Chung, M S Kang, J H Lee, J H Oh, H S Park, K S Yeo, S H Kang, S Y Song, Y K Kang, Y J Bang, Y H Kim, J P Kim.   

Abstract

We report 8 newly established gastric-carcinoma cell lines (SNU-216, 484, 520, 601, 620, 638, 668, 719) from Korean patients. Morphologic study was carried out using light and electron microscopes. CEA, alpha FP, and CA 19-9 and TPA in supernatant and in cell lysate were measured by radioimmunoassay. p53 and c-Ki-ras gene mutations were screened and confirmed by sequencing. The cell lines, derived from tumors with moderate differentiation, grew as a diffuse monolayer, and those from tumors with poor differentiation and minimal desmoplasia grew exclusively as non-adherent. Out of the 8 gastric-cancer cell lines, 5 had detectable levels of CEA both in supernatant and in cell lysate; there was no expression or secretion of alpha FP in these cells; 4 cell lines showed high levels of CA 19-9 in cell pellets. All cell lines except SNU-484 had high concentrations of TPA both in cell lysate and in supernatants. p53 mutation was found in 6 cell lines (75%): 2 (SNU-216 and SNU-668) had mutations in exon 6, and other 3 in exon 8. The c-Ki-ras mutation was found in 2 cell lines (25%), SNU-601 and SNU-668. The former showed GGT-to-GAT transition mutation at codon 12, while the latter showed CAA-to-AAA transversion mutation at codon 61. DNA profiles using restriction endonuclease HinfI and polymorphic DNA probes ChdTC-15 and ChdTC-114 showed different unique patterns; which suggests that these cell lines are unique and not cross-contaminated. We believe that the newly characterized gastric-cancer cell lines presented in this paper will provide a useful in vitro model for studies related to human gastric cancer.

Entities:  

Mesh:

Year:  1997        PMID: 9033653     DOI: 10.1002/(sici)1097-0215(19970207)70:4<443::aid-ijc12>3.0.co;2-g

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  39 in total

1.  The evolution of Epstein-Barr virus inferred from the conservation and mutation of the virus glycoprotein gp350/220 gene.

Authors:  Asako Kawaguchi; Kyosuke Kanai; Yukio Satoh; Chizu Touge; Keiko Nagata; Takeshi Sairenji; Yoshitsugu Inoue
Journal:  Virus Genes       Date:  2009-01-20       Impact factor: 2.332

2.  Epstein-Barr virus transcription activator R upregulates BARF1 expression by direct binding to its promoter, independent of methylation.

Authors:  E K Hoebe; C Wille; E S Hopmans; A R Robinson; J M Middeldorp; S C Kenney; A E Greijer
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

3.  Establishment and characterization of six human gastric carcinoma cell lines, including one naturally infected with Epstein-Barr virus.

Authors:  Ja-Lok Ku; Kyung-Hee Kim; Jin-Sung Choi; Sung-Hee Kim; Young-Kyoung Shin; Hee Jin Chang; Jae-Moon Bae; Young-Woo Kim; Jun Ho Lee; Han-Kwang Yang; Woo-Ho Kim; Seung-Yong Jeong; Jae-Gahb Park
Journal:  Cell Oncol (Dordr)       Date:  2012-02-24       Impact factor: 6.730

4.  Tumor specificity and in vivo targeting of an antibody against exon 9 deleted E-cadherin in gastric cancer.

Authors:  Hyuk-Joon Lee; Hye Seung Lee; Keun Hur; Woo Ho Kim; Kazuyoshi Yanagihara; Karl-Friedrich Becker; Kuhn Uk Lee; Han-Kwang Yang
Journal:  J Cancer Res Clin Oncol       Date:  2007-06-19       Impact factor: 4.553

5.  Transforming growth factor-beta 1 induces apoptosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells.

Authors:  Sang Gyun Kim; Hyun-Soon Jong; Tae-You Kim; Jung Weon Lee; Noe Kyeong Kim; Seung Hwan Hong; Yung-Jue Bang
Journal:  Mol Biol Cell       Date:  2003-10-31       Impact factor: 4.138

6.  Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma.

Authors:  Do Nyun Kim; Hiun-Suk Chae; Sang Taek Oh; Jin-Hyoung Kang; Cho Hyun Park; Won Sang Park; Kenzo Takada; Jae Myun Lee; Won-Keun Lee; Suk Kyeong Lee
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

7.  The synergism between Belotecan and cisplatin in gastric cancer.

Authors:  Joo Young Jung; Sang Hyun Song; Tae-Young Kim; Jung Hyun Park; Hyun-Soon Jong; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang; Noe Kyoung Kim
Journal:  Cancer Res Treat       Date:  2006-09-30       Impact factor: 4.679

8.  Biology of SNU cell lines.

Authors:  Ja-Lok Ku; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

9.  Regulation of glucose metabolism-related genes and VEGF by HIF-1alpha and HIF-1beta, but not HIF-2alpha, in gastric cancer.

Authors:  In Sung Song; Ai Guo Wang; Sun Young Yoon; Jeong Min Kim; Joo Heon Kim; Dong Seok Lee; Nam Soon Kim
Journal:  Exp Mol Med       Date:  2009-01-31       Impact factor: 8.718

10.  Methylation-dependent binding of the epstein-barr virus BZLF1 protein to viral promoters.

Authors:  Sarah J Dickerson; Yongna Xing; Amanda R Robinson; William T Seaman; Henri Gruffat; Shannon C Kenney
Journal:  PLoS Pathog       Date:  2009-03-27       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.